|
1
|
Cattaneo M: Hyperhomocysteinemia and
venous thromboembolism. Semin Thromb Hemost. 32:716–723. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Božič-Mijovski M: Hyperhomocysteinemia and
thrombophilia. Clin Chem Lab Med. 48(Suppl 1): S89–S95. 2010.
|
|
3
|
Aguilar B, Rojas JC and Collados MT:
Metabolism of homocysteine and its relationship with cardiovascular
disease. J Thromb Thrombolysis. 18:75–87. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Franchini M, Veneri D, Salvagno GL,
Manzato F and Lippi G: Inherited thrombophilia. Crit Rev Clin Lab
Sci. 43:249–290. 2006. View Article : Google Scholar
|
|
5
|
Melo SS, Persuhn DC, Meirelles MS, Jordao
AA and Vannucchi H: G1793A polymorphisms in the
methylenetetrahydrofolate gene: effect of folic acid on
homocysteine levels. Mol Nutr Food Res. 50:769–774. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kumar J, Garg G, Kumar A, et al: Single
nucleotide polymorphisms in homocysteine metabolism pathway genes:
association of CHDH A119C and MTHFR C677T with
hyperhomocysteinemia. Circ Cardiovasc Genet. 2:599–606. 2009.
View Article : Google Scholar
|
|
7
|
Legnani C, Palareti G, Grauso F, et al:
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate
reductase mutation (Ala223Val MTHFR) in patients with inherited
thrombophilic coagulation defects. Arterioscler Thromb Vasc Biol.
17:2924–2929. 1997. View Article : Google Scholar
|
|
8
|
D’Angelo A, Mazzola G and Fermo I:
Gene-gene and gene-environment interactions in mild
hyperhomocysteinemia. Pathophysiol Haemost Thromb. 33:337–341.
2003.PubMed/NCBI
|
|
9
|
Frosst P, Blom HJ, Milos R, et al: A
candidate genetic risk factor for vascular disease: a common
mutation in methylenetetrahydrofolate reductase. Nat Genet.
10:111–113. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Frederiksen J, Juul K, Grande P, Jensen
GB, Schroeder TV, Tybjaerg-Hansen A and Nordestgaard BG:
Methylenete-trahydrofolate reductase polymorphism (C677T),
hyperhomocysteinemia, and risk of ischemic cardiovascular disease
and venous thromboembolism: prospective and case-control studies
from the Copenhagen City Heart Study. Blood. 104:3046–3051. 2004.
View Article : Google Scholar
|
|
11
|
Khare A, Ghosh K, Kulkarni B and Mohanty
D: Thrombophilia: hereditary and acquired in cardiovascular
disease. Haematologia (Budap). 32:293–311. 2002.PubMed/NCBI
|
|
12
|
Greer IA: Inherited thrombophilia and
venous thromboembolism. Best Pract Res Clin Obstet Gynaecol.
17:413–425. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Martinelli I: Risk factors in venous
thromboembolism. Thromb Haemost. 86:395–403. 2001.PubMed/NCBI
|
|
14
|
Bereczky Z, Kovács KB and Muszbek L:
Protein C and protein S deficiencies: similarities and differences
between two brothers playing in the same game. Clin Chem Lab Med.
48(Suppl 1): S53–S66. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Castoldi E and Rosing J: APC resistance:
biological basis and acquired influences. J Thromb Haemost.
8:445–453. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Slavik L, Krcova V, Hlusi A, et al:
Molecular pathophysiology of thrombotic states and their impact to
laboratory diagnostics. Biomed Pap Med Fac Univ Palacky Olomouc
Czech Repub. 153:19–25. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Simioni P, Scudeller A and Girolami A:
Factor V Leiden and thrombophilia. N Engl J Med. 332:13821995.
|
|
18
|
Nguyen A: Prothrombin G20210A polymorphism
and thrombophilia. Mayo Clin Proc. 75:595–604. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hoţoleanu C, Porojan-Iuga M, Rusu ML and
Andercou A: Hyperhomocysteinemia: clinical and therapeutical
involvement in venous thrombosis. Rom J Intern Med. 45:159–164.
2007.PubMed/NCBI
|
|
20
|
Van Oijen MG, Vlemmix F, Laheij RJ,
Paloheimo L, Jansen JB and Verheugt FW: Hyperhomocysteinaemia and
vitamin B12 deficiency: the long-term effects in cardiovascular
disease. Cardiology. 107:57–62. 2007.PubMed/NCBI
|
|
21
|
Aksoy M, Basar Y, Salmayenli N, et al:
Hyperhomocysteinemia in patients with arterial occlusive disease.
Surg Today. 36:327–331. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ramakrishnan S, Sulochana KN, Lakshmi S,
Selvi R and Angayarkanni N: Biochemistry of homocysteine in health
and diseases. Indian J Biochem Biophys. 43:275–283. 2006.PubMed/NCBI
|
|
23
|
Cortese C and Motti C: MTHFR gene
polymorphism, homocysteine and cardiovascular disease. Public
Health Nutr. 4:493–497. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gemmati D, Serino ML, Trivellato C,
Fiorini S and Scapoli GL: C677T substitution in the
methylenetetrahydrofolate reductase gene as a risk factor for
venous thrombosis and arterial disease in selected patients.
Haematologica. 84:824–828. 1999.PubMed/NCBI
|
|
25
|
Couturaud F, Oger E, Abalain JH, et al:
Methylenetetrahydrofolate reductase C677T genotype and venous
thromboembolic disease. Respiration. 67:657–661. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Salomon O, Steinberg DM, Zivelin A, et al:
Single and combined prothrombotic factors in patients with
idiopathic venous thromboembolism: prevalence and risk assessment.
Arterioscler Thromb Vasc Biol. 19:511–518. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oger E, Lacut K, Le Gal G, et al; EDITH
COLLABORATIVE STUDY GROUP. Hyperhomocysteinemia and low B vitamin
levels are independently associated with venous thromboembolism:
results from the EDITH study: a hospital-based case-control study.
J Thromb Haemost. 4:793–799. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ray JG, Shmorgun D and Chan WS: Common
C677T polymorphism of the methylenetetrahydrofolate reductase gene
and the risk of venous thromboembolism: meta-analysis of 31
studies. Pathophysiol Haemost Thromb. 32:51–58. 2002. View Article : Google Scholar : PubMed/NCBI
|
